Loading
Latest filing published 06 Feb 2023 for Arbutus Biopharma Corporation.
No signal scores available.
Only one filing by Elizabeth Ann Howard is known so far (6 February 2023): a share grant, in Arbutus Biopharma Corporation. That is too little to draw conclusions. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration